德美化工(002054) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥504,558,016.31, representing a 23.89% increase compared to ¥407,278,468.97 in the same period last year[3] - Net profit attributable to shareholders was ¥43,552,356.77, up 36.10% from ¥32,000,861.67 year-on-year[3] - Basic earnings per share increased by 35.99% to ¥0.0903, compared to ¥0.0664 in the same period last year[3] - Operating profit for the period was ¥67,259,688.45, reflecting a 39.63% increase from ¥48,171,292.52 in the previous year[9] - The total profit for the period was ¥67,409,774.97, a 42.23% increase compared to ¥47,395,547.73 in the same period last year[9] - The company reported a significant increase in comprehensive income, totaling ¥67,817,805.26, which is a 61.19% rise from ¥42,074,011.90 year-on-year[9] - The net profit for Q1 2022 was CNY 61,602,477.75, representing a 50.5% increase from CNY 41,003,950.10 in Q1 2021[25] - The revenue from sales of goods and services received in Q1 2022 was CNY 360,524,306.06, up from CNY 322,939,770.31 in Q1 2021, indicating a growth of 11.6%[28] - The total operating costs for Q1 2022 were CNY 450,880,735.22, an increase of 23.1% compared to CNY 366,339,580.67 in Q1 2021[24] Cash Flow and Investments - The net cash flow from operating activities decreased by 79.23% to ¥3,242,609.57, down from ¥15,608,945.21 in the previous year[3] - Cash flow from operating activities decreased by 79.23%, with a net cash outflow of ¥172,444,255.26, improving by 42.92% from a previous outflow of ¥302,090,718.98[11] - Total cash inflow from investment activities was ¥23,730,166.23, a 75.20% increase from ¥13,544,931.53, mainly due to the recovery of financial assets[11] - Cash outflow for the purchase of fixed assets and other long-term assets was ¥196,174,421.49, down 36.85% from ¥310,635,650.51, attributed to changes in payments by a subsidiary[11] - The company reported a net cash increase of ¥586,590,339.73 at the end of the period, a decrease of 42.78% compared to ¥1,025,237,266.85 at the end of the previous period[11] - The cash and cash equivalents at the end of Q1 2022 were CNY 586,590,339.73, down from CNY 1,025,237,266.85 at the end of Q1 2021, a decrease of 42.8%[29] - The initial cash and cash equivalents balance was ¥722,063,985.88, reflecting a 44.93% increase from ¥498,216,285.80[11] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,933,801,210.89, a 4.55% increase from ¥5,675,419,258.88 at the end of the previous year[3] - Accounts receivable rose by 30.32% to ¥677,471,650.64, primarily due to increased sales revenue[7] - Inventory increased by 91.18% to ¥597,940,353.65, mainly due to raw materials and products during the trial production period of a subsidiary[7] - The company's current assets totaled CNY 2,411,309,739.86 as of March 31, 2022, up from CNY 2,246,874,937.78 at the beginning of the year, reflecting a growth of approximately 7.3%[19] - The total liabilities amounted to CNY 2,867,712,369.82, compared to CNY 2,679,008,498.81 at the start of the year, showing an increase of approximately 7.0%[21] - The company's non-current assets reached CNY 3,522,491,471.03, up from CNY 3,428,544,321.10, marking an increase of about 2.7%[20] - The total equity attributable to the parent company was CNY 2,471,335,056.12, compared to CNY 2,417,870,164.85 at the beginning of the year, indicating a growth of approximately 2.2%[21] Shareholder Information - The company plans to reduce its shareholding by up to 8,000,000 shares within six months following the disclosure of the reduction plan[15] - The company’s major shareholder, Huang Guanhong, holds a 19.37% stake, amounting to 93,406,344 shares[13] Management and Operations - The company appointed Mr. Zhang Mingzhi as the new vice president, following the retirement of Ms. Cai Jingxia due to reaching the legal retirement age[17] - The company completed the construction and commissioning of the first phase of the ethylene cracking by-product comprehensive utilization project, which is now in trial production[16] Research and Development - The company incurred research and development expenses of CNY 22,752,025.74 in Q1 2022, slightly down from CNY 23,473,673.86 in Q1 2021[24] - The company reported an investment income of CNY 20,030,644.08 in Q1 2022, which is an increase of 30.5% from CNY 15,293,494.05 in Q1 2021[24]